Volunteer studies: are current regulations adequate? the ethical dilemmaBABER, N. S.Pharmaceutical medicine (Basingstoke). 1994, Vol 8, Num 3-4, pp 153-159, issn 0265-0673Article

The scope of clinical pharmacology in the pharmaceutical industryBABER, N. S.British journal of clinical pharmacology. 1991, Vol 31, Num 5, pp 495-496, issn 0306-5251, 2 p.Article

Tripartite meeting. Paediatric regulatory guidelines : do they help in optimizing dose selection for children?BABER, N. S.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 660-662, issn 0306-5251, 3 p.Conference Paper

Ethical and scientific review procedures in the pharmaceutical industry: a survey of 12 British-based companiesGILL, L. S; BABER, N. S.Pharmaceutical medicine (Basingstoke). 1995, Vol 9, Num 1, pp 11-20, issn 0265-0673Article

Formulation of medicines for childrenNUNN, Tony; WILLIAMS, Julie.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 674-676, issn 0306-5251, 3 p.Conference Paper

How children's responses to drugs differ from adultsSTEPHENSON, Terence.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 670-673, issn 0306-5251, 4 p.Conference Paper

Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiologyHELMS, Peter J; DAUKES, Suzie Ekins; TAYLOR, Michael W et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 684-690, issn 0306-5251, 7 p.Conference Paper

The clinical section of the British Pharmacological Society : prospects for the futureBABER, N. S; TUCKER, G. T; WEBB, D. J et al.British journal of clinical pharmacology. 1997, Vol 44, Num 3, pp 215-218, issn 0306-5251Article

Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E₂ in healthy volunteers: a double blind investigationSCIBERRAS, D. G; GOLDENBERG, M. M; BOLOGNESE, J. A et al.British journal of clinical pharmacology. 1987, Vol 24, Num 6, pp 753-761, issn 0306-5251Article

Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary careNOVAK, Philipp H; EKINS-DAUKES, Suzie; SIMPSON, Colin R et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 712-717, issn 0306-5251, 6 p.Conference Paper

Effect of the Pediatric Exclusivity Provision on children's access to medicinesGRIEVE, Joanne; TORDOFF, June; REITH, David et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 730-735, issn 0306-5251, 6 p.Conference Paper

The clinical pharmacology, pharmacokinetics and metabolism of sumatriptanFOWLER, P. A; LACEY, L. F; THOMAS, M et al.European neurology. 1991, Vol 31, Num 5, pp 291-294, issn 0014-3022Conference Paper

Paediatric special issueBABER, N. S.British journal of clinical pharmacology. 2005, Vol 59, Num 6, issn 0306-5251, 114 p.Conference Proceedings

Paediatric homoeopathy in general practice : where, when and why?EKINS-DAUKES, Suzie; HELMS, Peter J; TAYLOR, Michael W et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 743-749, issn 0306-5251, 7 p.Conference Paper

Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beatsHANSTEEN, V; ENDRESEN, K; HELLEMANN, H et al.British journal of clinical pharmacology. 1984, Vol 17, Num 5, pp 579-584, issn 0306-5251Article

Better medicines for children : where are we now, and where do we want to be?ROSE, Klaus.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 657-659, issn 0306-5251, 3 p.Conference Paper

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling : theophylline and midazolam as model drugsBJÖRKMAN, Sven.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 691-704, issn 0306-5251, 14 p.Conference Paper

Changes in availability of paediatric medicines in Australia between 1998 and 2002CHUI, Jocelyn; TORDOFF, June; REITH, David et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 736-742, issn 0306-5251, 7 p.Conference Paper

In vitro fertilization and childhood retinoblastomaBENEZRA, David.British journal of clinical pharmacology. 2005, Vol 59, Num 6, issn 0306-5251, p. 724Conference Paper

Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years oldPRITCHARD, D. S; BABER, N; STEPHENSON, T et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 725-729, issn 0306-5251, 5 p.Conference Paper

The role of histamine in the acute inflammatory responses to intradermal platelet activating factorSCIBERRAS, D. G; JORDAN, S; GILL, D et al.British journal of clinical pharmacology. 1991, Vol 32, Num 1, pp 85-90, issn 0306-5251, 6 p.Article

Monitoring adverse drug reactions in children using community pharmacies : a pilot studySTEWART, Derek; HELMS, Peter; MCCAIG, Dorothy et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 677-683, issn 0306-5251, 7 p.Conference Paper

Allometric relationships between the pharmacokinetics of propofol in rats, children and adultsKNIBBE, Catherijne A. J; ZUIDEVELD, Klaas P; AARTS, Leon P. H. J et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 705-711, issn 0306-5251, 7 p.Conference Paper

Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospitalTITCHEN, Thirza; CRANSWICK, Noel; BEGGS, Sean et al.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 718-723, issn 0306-5251, 6 p.Conference Paper

Modelling approaches to dose estimation in childrenJOHNSON, Trevor N.British journal of clinical pharmacology. 2005, Vol 59, Num 6, pp 663-669, issn 0306-5251, 7 p.Conference Paper